This report analyzes the North American And European markets for Electronic Medical Record Systems in US$ Million. Annual forecasts are provided for the period 2006 through 2015. The report profiles 74 companies including many key [...]]]>

Research and Markets announced the addition of the “Electronic Medical Record Systems – Global Strategic Business Report” report to their offering.

This report analyzes the North American And European markets for Electronic Medical Record Systems in US$ Million. Annual forecasts are provided for the period 2006 through 2015. The report profiles 74 companies including many key and niche players such as Agfa-Gevaert Ltd., Ascribe plc, Cambio Healthcare Systems, Cambio Healthcare Systems, CompuGROUP HOLDING AG, Computer Programs and Systems, Inc., EBIT AET S.p.A., Eclipsys Corporation, Egton Medical Information Systems Limited, Epic Systems Corporation, GE Healthcare, Hewlett Packard Company, IBA Health (Europe) Ltd., IMS MAXIMS plc, Indra Sistemas SA, iSoft Group plc, McKesson Corporation, MDS Medical Software, MedPlus, Inc., Medical Information Technology, Inc., Medasys SA, Nexus AG, Noemalife SpA, Profdoc AB, QuadraMed Corporation, SAP (UK) Limited, Siemens Medical Solutions GSD GmbH, and System C Healthcare plc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. A NORTH AMERICAN AND EUROPEAN MARKET REPORT 1. INDUSTRY OVERVIEW 2. PRODUCT OVERVIEW 3. REGIONAL MARKET PERSPECTIVE 4. PRODUCT INNOVATIONS/INTRODUCTIONS 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT PLAYERS

III. COMPETITIVE LANDSCAPE

Total Companies Profiled: 106 (including Divisions/Subsidiaries – 110)

Share/Save

The new facility will specialise in the manufacturing of high-quality intravenous solutions for medical treatments.

The launch of Wellpharma Medical Solutions Fund is [...]]]>

Wellpharma Holding, a company set up recently by Abu Dhabi Investment House, or ADIH, has launched a healthcare fund to raise finance to invest in a pharmaceutical plant to be established in the emmirate.

The new facility will specialise in the manufacturing of high-quality intravenous solutions for medical treatments.

The launch of Wellpharma Medical Solutions Fund is in line with Abu Dhabi Investment House’s strategy to diversify its investment products to venture into new sectors such as food security, energy and clean energy and healthcare.

The Ministry of Health and Health Authority in Abu Dhabi, or HAAD, have already agreed in principle to allow setting up of an intravenous solutions project in the emirate, a spokesperson of 
ADIH said.

Land for the project is being allocated as well as an industrial partner to help in building and operating the facility has also been identified.

“The Wellpharma Medical Solutions project will be the first among many in ADIH’s ‘Wellpharma’ product range. Other initiatives will include medical office buildings and other innovative medical products,” the investment house said.

The opportunity was identified after a thorough due diligence and realisation of current market situation where huge scope exists for such economic projects.

“The fund will take into consideration local and regional gaps in supply and demand of Intravenous Solutions to ensure the best returns,” he said.

Increasing gap between supply and demand as well as the implementation of mandatory health insurance within the GCC region will expand the healthcare sector by eight per cent annually in the next five years, the ADIH said.

Share/Save